BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37577706)

  • 1. Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients.
    Zinter MS; Brazauskas R; Strom J; Chen S; Bo-Subait S; Sharma A; Beitinjaneh A; Dimitrova D; Guilcher G; Preussler J; Myers K; Bhatt NS; Ringden O; Hematti P; Hayashi RJ; Patel S; De Oliveira SN; Rotz S; Badawy SM; Nishihori T; Buchbinder D; Hamilton B; Savani B; Schoemans H; Sorror M; Winestone L; Duncan C; Phelan R; Dvorak CC
    medRxiv; 2023 Aug; ():. PubMed ID: 37577706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.
    Zinter MS; Brazauskas R; Strom J; Chen S; Bo-Subait S; Sharma A; Beitinjaneh A; Dimitrova D; Guilcher G; Preussler J; Myers K; Bhatt NS; Ringden O; Hematti P; Hayashi RJ; Patel S; De Oliveira SN; Rotz S; Badawy SM; Nishihori T; Buchbinder D; Hamilton B; Savani B; Schoemans H; Sorror M; Winestone L; Duncan C; Phelan R; Dvorak CC
    Blood Adv; 2024 Feb; 8(4):1002-1017. PubMed ID: 38127268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.
    Zinter MS; Logan BR; Fretham C; Sapru A; Abraham A; Aljurf MD; Arnold SD; Artz A; Auletta JJ; Chhabra S; Copelan E; Duncan C; Gale RP; Guinan E; Hematti P; Keating AK; Marks DI; Olsson R; Savani BN; Ustun C; Williams KM; Pasquini MC; Dvorak CC
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):333-342. PubMed ID: 31563573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes.
    Smith MA; Cheng G; Phelan R; Brazauskas R; Strom J; Ahn KW; Hamilton BK; Peterson A; Savani B; Schoemans H; Schoettler ML; Sorror M; Keller RL; Higham CS; Dvorak CC; Fineman JR; Zinter MS
    Front Oncol; 2024; 14():1415984. PubMed ID: 38868534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Hematopoietic Cell Transplant Patients Who Survive Critical Illness Frequently Have Significant but Recoverable Decline in Functional Status.
    Zinter MS; Holubkov R; Steurer MA; Dvorak CC; Duncan CN; Sapru A; Tamburro RF; McQuillen PS; Pollack MM
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):330-336. PubMed ID: 29128553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.
    Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A
    Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation.
    Jacobe SJ; Hassan A; Veys P; Mok Q
    Crit Care Med; 2003 May; 31(5):1299-305. PubMed ID: 12771594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
    Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR
    Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018.
    Valcarcel B; Schonfeld SJ; Meyer CL; Brunson A; Cooley JJP; Abrahão R; Wun T; Auletta JJ; Gadalla SM; Engels E; Albert PS; Spellman SR; Rizzo JD; Shaw BE; Muffly L; Keegan THM; Morton LM
    Transplant Cell Ther; 2024 Feb; 30(2):239.e1-239.e11. PubMed ID: 37981238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with pediatric intensive care unit admission and mortality after pediatric stem cell transplant: possible role of renal involvement.
    Hassan NE; Mageed AS; Sanfilippo DJ; Reischman D; Duffner UA; Rajasekaran S
    World J Pediatr; 2013 May; 9(2):140-5. PubMed ID: 23275103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Hematopoietic Stem Cell Transplant and Intensive Care: Have Things Changed?
    Balit CR; Horan R; Dorofaeff T; Frndova H; Doyle J; Cox PN
    Pediatr Crit Care Med; 2016 Mar; 17(3):e109-16. PubMed ID: 26673844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors and Outcomes Related to Pediatric Intensive Care Unit Admission after Hematopoietic Stem Cell Transplantation: A Single-Center Experience.
    Pillon M; Amigoni A; Contin A; Cattelan M; Carraro E; Campagnano E; Tumino M; Calore E; Marzollo A; Mainardi C; Boaro MP; Nizzero M; Pettenazzo A; Basso G; Messina C
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1335-1341. PubMed ID: 28461212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).
    Gabriel M; Shaw BE; Brazauskas R; Chen M; Margolis DA; Sengelov H; Dahlberg A; Ahmed IA; Delgado D; Lazarus HM; Gibson B; Myers KC; Kamble RT; Abdel-Mageed A; Li CK; Flowers MED; Battiwalla M; Savani BN; Majhail N; Shaw PJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1320-1326. PubMed ID: 28411175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights Into Multicenter PICU Mortality Among Pediatric Hematopoietic Stem Cell Transplant Patients.
    Zinter MS; Dvorak CC; Spicer A; Cowan MJ; Sapru A
    Crit Care Med; 2015 Sep; 43(9):1986-94. PubMed ID: 26035280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
    Bona K; Brazauskas R; He N; Lehmann L; Abdel-Azim H; Ahmed IA; Al-Homsi AS; Aljurf M; Arnold SD; Badawy SM; Battiwalla M; Beattie S; Bhatt NS; Dalal J; Dandoy CE; Diaz MA; Frangoul HA; Freytes CO; Ganguly S; George B; Gomez-Almaguer D; Hahn T; Kamble RT; Knight JM; LeMaistre CF; Law J; Lazarus HM; Majhail NS; Olsson RF; Preussler J; Savani BN; Schears R; Seo S; Sharma A; Srivastava A; Steinberg A; Szwajcer D; Wirk B; Yoshimi A; Khera N; Wood WA; Hashmi S; Duncan CN; Saber W
    Blood; 2021 Jan; 137(4):556-568. PubMed ID: 33104215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry.
    Gillis N; Padron E; Wang T; Chen K; DeVos JD; Spellman SR; Lee SJ; Kitko CL; MacMillan ML; West J; Tang YH; Teng M; McNulty S; Druley TE; Pidala JA; Lazaryan A
    Transplant Cell Ther; 2023 Oct; 29(10):640.e1-640.e8. PubMed ID: 37517612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortality.
    Zaidman I; Mohamad H; Shalom L; Ben Arush M; Even-Or E; Averbuch D; Zilkha A; Braun J; Mandel A; Kleid D; Attias O; Ben-Ari J; Brooks R; Gefen A; Stepensky P
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29549. PubMed ID: 34968007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients.
    Heybati K; Ochal D; Hogan W; Al-Khateeb H; Sklar D; Herasevich S; Litzow M; Shah M; Torghabeh MH; Durani U; Bauer P; Gajic O; Yadav H
    Ann Hematol; 2024 Mar; 103(3):957-967. PubMed ID: 38170240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.